Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInt.biotech. Share News (IBT)

Share Price Information for Int.biotech. (IBT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 638.00
Bid: 632.00
Ask: 640.00
Change: -10.00 (-1.54%)
Spread: 8.00 (1.266%)
Open: 646.00
High: 646.00
Low: 638.00
Prev. Close: 648.00
IBT Live PriceLast checked at -
International Biotechnology is an Investment Trust

To achieve capital growth through investing in high growth, development stage biotechnology companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DIRECTOR DEALINGS: MD of Gleeson Homes buys GBP150,000 in shares

Tue, 02nd Nov 2021 15:20

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Tuesday and not separately reported by Alliance News:

----------

MJ Gleeson PLC - Sheffield, England-based housebuilder - Mark Knight, managing director of Gleeson Homes, buys 18,795 shares at GBP7.94, worth GBP149,232, on Monday. Knight now has 33,682 shares, a 0.1% stake.

----------

accesso Technology Group PLC - Berkshire, England-based provider of software for leisure, entertainment and cultural sectors - Non-Executive Chair Bill Russell buys 8,200 shares at USD12.37, worth USD101,393, in the US on Friday last week. Now has 53,507 shares, a 0.1% stake.

----------

Riverstone Credit Opportunities Income PLC - aims to generate returns by making loans to companies in energy sector - Director Reuben Jeffery buys 50,000 shares at USD0.86, worth USD43,130, on Monday.

----------

International Biotechnology Trust PLC - investment trust run by SV Health Managers LLP - Non-Executive Director Patrick Magee buys 4,000 shares at 735 pence, worth GBP29,400, on Tuesday. Now has 7,500 shares.

----------

Headlam Group PLC - Birmingham-based floorcoverings distributor - Independent Non-Executive Director Stephen Bird buys 5,000 shares at 462.60p, worth GBP23,130, on Monday.

----------

Scancell Holdings PLC - Oxford, England-based immunotherapies for treatment of cancer and infectious disease - Non-Executive Director Martin Diggle buys 100,000 shares via Vulpes Life Sciences Fund at 19 pence, worth about GBP19,000, on Friday last week. Vulpes now has 117.3 million shares, a 14.4% stake.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
20 Apr 2020 16:07

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
26 Feb 2020 16:22

DIRECTOR DEALINGS: International Biotechnology Director Buys Shares

DIRECTOR DEALINGS: International Biotechnology Director Buys Shares

Read more
11 Dec 2019 17:48

International Biotechnology Trust Declares 12.4 Pence Dividend

International Biotechnology Trust Declares 12.4 Pence Dividend

Read more
29 Oct 2019 13:27

International Biotechnology Net Assets Down But Outperforms Benchmark

International Biotechnology Net Assets Down But Outperforms Benchmark

Read more
10 Jul 2019 16:44

International Biotechnology Declares 14 Pence Interim Dividend

(Alliance News) - International Biotechnology Trust PLC said Wednesday it has declared a 14 pence per share second interim dividend for the year to the end of August.The investment company

Read more
25 Apr 2019 15:26

International Biotechnology Trust Sees Mixed Performance In First Half

LONDON (Alliance News) - International Biotechnology Trust PLC said Thursday it saw a mixed performance against its comparative indices in the first half of its financial year, despite a rise in a

Read more
30 Oct 2018 17:36

International Biotechnology Net Asset Value Rises Despite Volatility

LONDON (Alliance News) - International Biotechnology Trust PLC said Tuesday that its annual net asset value per share increased by 8.6% despite market volatility.For the year ended August a

Read more
13 Dec 2016 17:17

Trump Effect Hits Latin American, Gold Funds In November - QuotedData

Read more
4 Nov 2016 08:27

International Biotechnology Shares Drop As Full Year Returns Suffer

Read more
8 Sep 2016 11:18

Crystal Amber Sparkles Among Investment Funds In August - QuotedData

Read more
5 Aug 2016 12:59

Best And Worst Performing London-Listed Funds In July - QuotedData

Read more
9 Jun 2016 14:22

Best And Worst Performing London-Listed Funds In May - QuotedData

Read more
9 Jun 2016 14:20

Biotech And Healthcare Funds Enjoyed Small Rally In May - QuotedData

Read more
18 Apr 2016 10:06

International Biotechnology Says US Election Pressuring Biotech Stocks

Read more
18 Feb 2016 17:47

DIRECTOR DEALINGS: International Biotechnology Non-Exec Ups Stake

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.